Spasticity as Sequela of Stroke: Clinical Trials

3 trials for Spasticity as Sequela of Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Spasticity as Sequela of Stroke: new trials by email Literature Review of Spasticity as Sequela of Stroke trials Research Report on Spasticity as Sequela of Stroke

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections
Hand of Hope, Botulinum toxin type A injection - Chronic Stroke, Spasticity as Sequela of Stroke
Phase 2CompletedCheng-Hsin General Hospital242020-01-092024-03-19
Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness
Real soft splint (6 cm), Placebo soft splint (1 cm) - Brain Injuries, Disorder of Consciousness
Phase 2CompletedGéraldine Martens122017-01-012019-09-25
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
sham Doublestim, anodal Doublestim - Stroke, Cerebrovascular Accident (CVA)
Phase 1 / Phase 2CompletedNorthwell Health262016-09-012021-04-05

Narrower conditions

Stroke (2)  ·  Brain Injuries (1)  ·  Central Nervous System Diseases (1)  ·  Consciousness Disorders (1)  ·  Contracture (1)  ·  Craniocerebral Trauma (1)  ·  Muscle Spasticity (1)  ·  Neurocognitive Disorders (1)  ·  Paresis (1)  ·  Pathologic Processes (1)  ·  Trauma, Nervous System (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Central Nervous System Diseases (1)  ·  Joint Diseases (1)  ·  Mental Disorders (1)  ·  Muscle Hypertonia (1)  ·  Neurobehavioral Manifestations (1)

Interventions

Botulinum Toxins, Type A (1)

Sponsors

Cheng-Hsin General Hospital (1)  ·  GĂ©raldine Martens (1)  ·  Northwell Health (1)

Countries

Belgium (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Nicolas Lejeune (1)

Results publications

PMID 32232101